ZA846826B - Oxamic acid derivates - Google Patents
Oxamic acid derivatesInfo
- Publication number
- ZA846826B ZA846826B ZA846826A ZA846826A ZA846826B ZA 846826 B ZA846826 B ZA 846826B ZA 846826 A ZA846826 A ZA 846826A ZA 846826 A ZA846826 A ZA 846826A ZA 846826 B ZA846826 B ZA 846826B
- Authority
- ZA
- South Africa
- Prior art keywords
- carbon atoms
- alkoxy
- hydrogen
- amino
- alkyl
- Prior art date
Links
- SOWBFZRMHSNYGE-UHFFFAOYSA-N oxamic acid Chemical compound NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 title 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 abstract 1
- 206010010741 Conjunctivitis Diseases 0.000 abstract 1
- 208000004262 Food Hypersensitivity Diseases 0.000 abstract 1
- 208000024780 Urticaria Diseases 0.000 abstract 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 201000009961 allergic asthma Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000020932 food allergy Nutrition 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 206010039083 rhinitis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/12—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/16—Halogen atoms; Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Materials For Medical Uses (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52852283A | 1983-09-01 | 1983-09-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA846826B true ZA846826B (en) | 1986-04-30 |
Family
ID=24106021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA846826A ZA846826B (en) | 1983-09-01 | 1984-08-31 | Oxamic acid derivates |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0137979B1 (cs) |
| JP (1) | JPS60142968A (cs) |
| KR (1) | KR900001217B1 (cs) |
| AT (1) | ATE38224T1 (cs) |
| AU (1) | AU569541B2 (cs) |
| CA (1) | CA1219873A (cs) |
| CS (1) | CS241100B2 (cs) |
| DD (1) | DD227964A5 (cs) |
| DE (1) | DE3474817D1 (cs) |
| DK (1) | DK158725C (cs) |
| ES (1) | ES8505934A1 (cs) |
| FI (1) | FI84477C (cs) |
| GR (1) | GR80245B (cs) |
| HU (1) | HU192576B (cs) |
| IE (1) | IE59035B1 (cs) |
| IL (1) | IL72833A (cs) |
| NO (1) | NO843477L (cs) |
| NZ (1) | NZ209405A (cs) |
| PH (1) | PH22753A (cs) |
| PT (1) | PT79163B (cs) |
| SU (1) | SU1342410A3 (cs) |
| ZA (1) | ZA846826B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62145049A (ja) * | 1985-12-18 | 1987-06-29 | Mitsubishi Chem Ind Ltd | アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤 |
| WO1992000963A1 (en) * | 1990-07-12 | 1992-01-23 | Yoshitomi Pharmaceutical Industries, Ltd. | Styryl compounds and use thereof as medicine |
| JP2832923B2 (ja) * | 1990-07-13 | 1998-12-09 | 吉富製薬株式会社 | スチリル化合物およびその医薬用途 |
| PE20000174A1 (es) * | 1998-01-12 | 2000-03-17 | Novartis Ag | Piridinilpirimidinaminas |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1259685A (en) * | 1969-04-03 | 1972-01-12 | Soc D Etudes Prod Chimique | Amino-pyrimidine derivatives |
| US3993679A (en) * | 1972-12-20 | 1976-11-23 | The Upjohn Company | Cyano phenylene dioxamic molecules |
| US4054666A (en) * | 1973-03-23 | 1977-10-18 | American Home Products Corporation | Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives |
| US3953468A (en) * | 1974-03-15 | 1976-04-27 | The Upjohn Company | 3-Cyano thiophen-2-yl oxamic acid and derivatives |
| CA1066714A (en) * | 1974-06-10 | 1979-11-20 | John B. Wright | Pharmaceutical n-phenyloxamic acid derivatives |
| DE2828091A1 (de) * | 1978-06-27 | 1980-01-10 | Boehringer Sohn Ingelheim | 4-substituierte thiazoloxamsaeuren sowie ihre salze und ester |
| JPS5761028A (en) * | 1980-09-30 | 1982-04-13 | Sanyo Chem Ind Ltd | Formation of heat-insulating primer layer and heat-insulating structure |
-
1984
- 1984-08-23 EP EP84110036A patent/EP0137979B1/en not_active Expired
- 1984-08-23 AT AT84110036T patent/ATE38224T1/de not_active IP Right Cessation
- 1984-08-23 DE DE8484110036T patent/DE3474817D1/de not_active Expired
- 1984-08-29 GR GR80245A patent/GR80245B/el unknown
- 1984-08-29 SU SU843784980A patent/SU1342410A3/ru active
- 1984-08-30 CS CS846545A patent/CS241100B2/cs unknown
- 1984-08-30 FI FI843417A patent/FI84477C/fi not_active IP Right Cessation
- 1984-08-30 PH PH31168A patent/PH22753A/en unknown
- 1984-08-31 IL IL72833A patent/IL72833A/xx not_active IP Right Cessation
- 1984-08-31 ES ES535572A patent/ES8505934A1/es not_active Expired
- 1984-08-31 NO NO843477A patent/NO843477L/no unknown
- 1984-08-31 HU HU843293A patent/HU192576B/hu not_active IP Right Cessation
- 1984-08-31 ZA ZA846826A patent/ZA846826B/xx unknown
- 1984-08-31 DD DD84266851A patent/DD227964A5/de not_active IP Right Cessation
- 1984-08-31 AU AU32600/84A patent/AU569541B2/en not_active Ceased
- 1984-08-31 IE IE223784A patent/IE59035B1/en not_active IP Right Cessation
- 1984-08-31 KR KR1019840005354A patent/KR900001217B1/ko not_active Expired
- 1984-08-31 NZ NZ209405A patent/NZ209405A/en unknown
- 1984-08-31 JP JP59182553A patent/JPS60142968A/ja active Pending
- 1984-08-31 PT PT79163A patent/PT79163B/pt not_active IP Right Cessation
- 1984-08-31 CA CA000462219A patent/CA1219873A/en not_active Expired
- 1984-08-31 DK DK418484A patent/DK158725C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK158725C (da) | 1990-12-10 |
| IE59035B1 (en) | 1993-12-15 |
| CA1219873A (en) | 1987-03-31 |
| IE842237L (en) | 1985-03-01 |
| FI843417A0 (fi) | 1984-08-30 |
| FI843417A7 (fi) | 1985-03-02 |
| DK418484D0 (da) | 1984-08-31 |
| KR850002258A (ko) | 1985-05-10 |
| ES535572A0 (es) | 1985-06-16 |
| DD227964A5 (de) | 1985-10-02 |
| GR80245B (en) | 1985-01-03 |
| HU192576B (en) | 1987-06-29 |
| PH22753A (en) | 1988-11-28 |
| KR900001217B1 (ko) | 1990-02-28 |
| EP0137979B1 (en) | 1988-10-26 |
| SU1342410A3 (ru) | 1987-09-30 |
| PT79163A (en) | 1984-09-01 |
| FI84477B (fi) | 1991-08-30 |
| AU569541B2 (en) | 1988-02-04 |
| IL72833A (en) | 1987-09-16 |
| PT79163B (en) | 1986-11-18 |
| HUT37129A (en) | 1985-11-28 |
| JPS60142968A (ja) | 1985-07-29 |
| CS654584A2 (en) | 1985-07-16 |
| NZ209405A (en) | 1987-05-29 |
| DE3474817D1 (en) | 1988-12-01 |
| DK158725B (da) | 1990-07-09 |
| EP0137979A1 (en) | 1985-04-24 |
| AU3260084A (en) | 1985-03-07 |
| CS241100B2 (en) | 1986-03-13 |
| DK418484A (da) | 1985-03-02 |
| NO843477L (no) | 1985-03-04 |
| ATE38224T1 (de) | 1988-11-15 |
| ES8505934A1 (es) | 1985-06-16 |
| FI84477C (fi) | 1991-12-10 |
| IL72833A0 (en) | 1984-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU590798B2 (en) | Dihydrobenzopyran derivatives | |
| NO965305D0 (no) | Nye forbindelser, fremgangsmåter ved deres fremstilling og anti-tumormidler | |
| ATE17249T1 (de) | 9-(2-(3-indolyl)aethyl)-1-oxa-4,9diazaspiro(5.5)undecan-3-one. | |
| IE820401L (en) | N-£4-(indolyl)-piperidino-alkyl|-benzimidazolines | |
| IN164295B (cs) | ||
| ZA846826B (en) | Oxamic acid derivates | |
| DE3786109D1 (de) | Pyrido(2,3-d)pyrimidin-derivate. | |
| UA66888C2 (uk) | 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів | |
| AU586442B2 (en) | Bis (arylpiperazinyl) Sulfur compounds | |
| DE3785076D1 (de) | Pyrido(4,3-d)pyrimidin-derivate. | |
| JPS6479178A (en) | Thiazole derivative | |
| JPS5753463A (en) | Omega-aminoalkoxyphenylpyarazole and its acid addition salt |